The tobacco smoking prolongation and intensity influence on the community-acquired pneumonia course

T. V. Shjukina, V. I. Trofimov, N. L. Shaporova (St Petersburg, Russia)

Source: Annual Congress 2004 - Tobacco smoking and respiratory disease
Session: Tobacco smoking and respiratory disease
Session type: Thematic Poster Session
Number: 1002
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. V. Shjukina, V. I. Trofimov, N. L. Shaporova (St Petersburg, Russia). The tobacco smoking prolongation and intensity influence on the community-acquired pneumonia course. Eur Respir J 2004; 24: Suppl. 48, 1002

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The tobacco-smoking influence on the community-acquired pneumonia course
Source: Eur Respir J 2006; 28: Suppl. 50, 247s
Year: 2006

The influence of smoking habit in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003

Nosocomial pneumonia: influence of smoking on the course of disease
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007


The impact of smoking on community acquired pneumonia course and outcomes
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


The main risk factors of the community-acquired pneumonia delayed course
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005

The influence of anxiety on the behavior of smoking in patients with community-acquired pneumonia
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


COPD: what is the frequency and impact of community-acquired pneumonia?
Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know?
Year: 2008


The relation between degree of smoking addiction and community acquired pneumonia
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007


Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia?
Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know?
Year: 2008


The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome
Source: Eur Respir J 2007; 30: Suppl. 51, 675s
Year: 2007

The post-tuberculosis lung changes as risk factor of the community-acquired pneumonia delayed course
Source: Eur Respir J 2006; 28: Suppl. 50, 351s
Year: 2006

7-day course of antibiotics had similar efficacy to prolonged course in severe community-acquired pneumonia: a propensity-adjusted analysis
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010

The effect of hospitalization and disease itself on smoking sessation of patients with tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 155s
Year: 2004

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment
Source: Eur Respir J 2008; 32: 139-146
Year: 2008



How often can we use short course therapy in patients with hospital-acquired pneumonia?
Source: Eur Respir J 2007; 30: Suppl. 51, 408s
Year: 2007

The prevalence of smoking in HIV-infected patients with community-acquired pneumonia
Source: International Congress 2015 – Epidemiology, public health and economics of tobacco
Year: 2015


Prolonged hospitalization in community-acquired pneumonia. Influence of clinical factors and hospital characteristics
Source: Eur Respir J 2003; 22: Suppl. 45, 544s
Year: 2003

Alcohol drinking and risk of subsequent hospitalisation with pneumonia
Source: Eur Respir J 2012; 39: 149-155
Year: 2012



Alcohol drinking and risk of subsequent hospitalisation with pneumonia
Source: Eur Respir J 2011; 39: 149-155
Year: 2012



3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors
Source: Eur Respir J 2016; 47:1572-1574
Year: 2016